F Grotenhermen

Summary

Affiliation: Nova-Institut GmbH
Country: Germany

Publications

  1. ncbi Cannabis-associated arteritis
    F Grotenhermen
    Nova Institut, Hürth, Germany
    Vasa 39:43-53. 2010
  2. ncbi Pharmacokinetics and pharmacodynamics of cannabinoids
    Franjo Grotenhermen
    Nova Institut, Hürth, Germany
    Clin Pharmacokinet 42:327-60. 2003
  3. ncbi How to prevent cannabis-induced psychological distress...in politicians
    Franjo Grotenhermen
    Nova-Institut GmbH, D-50354 Huerth, Germany
    Lancet 363:1568-9. 2004
  4. ncbi Developing limits for driving under cannabis
    Franjo Grotenhermen
    Nova Institut, Hürth, Germany
    Addiction 102:1910-7. 2007
  5. ncbi Cannabinoids
    Franjo Grotenhermen
    Nova Institut, Goldenbergstrasse 2, D 50354 Hürth, Germany
    Curr Drug Targets CNS Neurol Disord 4:507-30. 2005
  6. ncbi Pharmacology of cannabinoids
    Franjo Grotenhermen
    Nova Institut, Goldenbergstrasse 2, D 50354 Huerth, Germany
    Neuro Endocrinol Lett 25:14-23. 2004
  7. ncbi IACM 2nd Conference on Cannabinoids in Medicine
    Franjo Grotenhermen
    Nova Institut, Goldenbergstrasse 2, 50354 Hürth, Germany
    Expert Opin Pharmacother 4:2367-71. 2003
  8. ncbi [Some practice-relevant aspects of the pharmacokinetics of THC]
    F Grotenhermen
    Nova Institut, Hürth, Germany
    Forsch Komplementarmed 6:37-9. 1999
  9. ncbi [The effects of cannabis and THC]
    F Grotenhermen
    Nova Institut, Hürth, Germany
    Forsch Komplementarmed 6:7-11. 1999
  10. ncbi The toxicology of cannabis and cannabis prohibition
    Franjo Grotenhermen
    Nova Institut, Goldenbergstrasse 2, D 50354 Hürth
    Chem Biodivers 4:1744-69. 2007

Detail Information

Publications10

  1. ncbi Cannabis-associated arteritis
    F Grotenhermen
    Nova Institut, Hürth, Germany
    Vasa 39:43-53. 2010
    ..To investigate the hypothesis that cases of arteritis similar to thromboangiitis obliterans (TAO) and associated with the use of cannabis were caused by cannabis or THC (dronabinol), or that cannabis use is a co-factor of TAO...
  2. ncbi Pharmacokinetics and pharmacodynamics of cannabinoids
    Franjo Grotenhermen
    Nova Institut, Hürth, Germany
    Clin Pharmacokinet 42:327-60. 2003
    ....
  3. ncbi How to prevent cannabis-induced psychological distress...in politicians
    Franjo Grotenhermen
    Nova-Institut GmbH, D-50354 Huerth, Germany
    Lancet 363:1568-9. 2004
  4. ncbi Developing limits for driving under cannabis
    Franjo Grotenhermen
    Nova Institut, Hürth, Germany
    Addiction 102:1910-7. 2007
    ..Development of a rational and enforceable basis for controlling the impact of cannabis use on traffic safety...
  5. ncbi Cannabinoids
    Franjo Grotenhermen
    Nova Institut, Goldenbergstrasse 2, D 50354 Hürth, Germany
    Curr Drug Targets CNS Neurol Disord 4:507-30. 2005
    ..Additional potential was proposed for the treatment of alcohol and heroine dependency, schizophrenia, conditions with lowered blood pressure, Parkinson's disease and memory impairment in Alzheimer's disease...
  6. ncbi Pharmacology of cannabinoids
    Franjo Grotenhermen
    Nova Institut, Goldenbergstrasse 2, D 50354 Huerth, Germany
    Neuro Endocrinol Lett 25:14-23. 2004
    ....
  7. ncbi IACM 2nd Conference on Cannabinoids in Medicine
    Franjo Grotenhermen
    Nova Institut, Goldenbergstrasse 2, 50354 Hürth, Germany
    Expert Opin Pharmacother 4:2367-71. 2003
    ..It was concluded that possible side effects of cannabinoids should be taken into account but do not preclude a legitimate medical use...
  8. ncbi [Some practice-relevant aspects of the pharmacokinetics of THC]
    F Grotenhermen
    Nova Institut, Hürth, Germany
    Forsch Komplementarmed 6:37-9. 1999
    ..Heating of 5 min to 200 degrees C seems to be optimal...
  9. ncbi [The effects of cannabis and THC]
    F Grotenhermen
    Nova Institut, Hürth, Germany
    Forsch Komplementarmed 6:7-11. 1999
    ..Disturbance of immunological and hormonal functions and long-term impairment of memory, attention, and complex cognitive processes are low and do not preclude a legitimate therapeutic use...
  10. ncbi The toxicology of cannabis and cannabis prohibition
    Franjo Grotenhermen
    Nova Institut, Goldenbergstrasse 2, D 50354 Hürth
    Chem Biodivers 4:1744-69. 2007
    ..Harm is greatest for seriously ill people who may benefit from a treatment with cannabis. This makes it difficult to justify criminal penalties against patients...